FindTrial
Sign In

A Study on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Combined with APACHE? Score in Predicting the Prognosis of Sepsis Patients

The Value of Combined Detection of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and APACHE ? Score in Prognostic Assessment of Patients with Sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126871
Enrollment
Unknown
Registered
2026-06-17
Start date
2025-12-08
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Death Group vs Survival Group:None

Sponsors

Dandong Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the Sepsis 3.0 diagnostic criteria; 2. Age > 18 years old; 3. Complete clinical data of patients.

Exclusion criteria

Exclusion criteria: 1. Presence of malignant tumors, acute infectious diseases, etc. 2. Presence of immune system diseases; 3. Pregnancy or lactation; 4. Receipt of blood or blood products within 14 days; 5. Use of immunosuppressive drugs within 3 months; 6. ICU hospitalization duration <=1 day; 7. Chemotherapy administered within 6 months before admission.

Design outcomes

Primary

MeasureTime frame
Neutrophil-to-Lymphocyte Ratio;APACHE? Score;Platelet-to-Lymphocyte Ratio;—

Countries

China

Contacts

Public ContactYuan Haimei

Dandong Central Hospital

1097259910@qq.com+86 415 616 1984

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026